Lv2
188 积分 2025-10-08 加入
Preclinical evaluation of antigen-specific B-cell depletion for phospholipase A2 receptor membranous nephropathy with chimeric autoantibody receptor T cells
1天前
已完结
The Case | Relapsing nephrotic syndrome
7天前
已完结
Diabetes mellitus attenuates response to anti-CD20 therapy in primary membranous nephropathy despite equivalent B-cell depletion
7天前
已完结
Long-term kidney protection in IgA nephropathy with atrasentan
11天前
已完结
A Step Forward — Obinutuzumab for Membranous Nephropathy
13天前
已完结
Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
21天前
已完结
What’s New in Membranous Nephropathy and How to Incorporate New Antigen Discoveries Into Clinical Practice: A Review
23天前
已完结
Tiny warriors, big impact: targeted immunotherapy in kidney diseases
23天前
已完结
The Case | Relapsing nephrotic syndrome
23天前
已完结
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
23天前
已完结
皖公网安备34019202002308
